Showing results (161-170 of 173) with videos related to
Sort By:
Pageof 18
The Journal of Allergy and Clinical Immunology|December 27, 2011
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiencyTeresa Caballero, Henriette Farkas, Laurence Bouillet, et al.European Journal of Medical Genetics|July 2, 2022
Surveillance and monitoring in vascular Ehlers-Danlos syndrome in European Reference Network For Rare Vascular Diseases (VASCERN)Ingrid M B H van de Laar, Annette F Baas, Julie De Backer, et al.Clinical and Experimental Rheumatology|May 19, 2022
Atypical variants in COL1A1 and COL3A1 associated with classical and vascular Ehlers-Danlos syndrome overlap phenotypes: expanding the clinical phenotype based on additional case reportsMarlies Colman, Marco Castori, Lucia Micale, et al.Orphanet Journal of Rare Diseases|December 5, 2021
Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndromeClarisse Billon, Salma Adham, Natalia Hernandez Poblete, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2019
Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibilityNeeti Ghali, Duncan Baker, Angela F Brady, et al.Orphanet Journal of Rare Diseases|June 27, 2026
Management of pregnancy in women with rare multisystemic vascular diseases: a qualitative survey analysisGloria Somalo-Barranco, Alexandra Benachi, Laurence M Boon, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2022
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIVEdgar T Overton, Isabelle R Weir, Markella V Zanni, et al.Circulation|February 5, 2025
Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos SyndromeXavier Jeunemaitre, Elie Mousseaux, Michael Frank, et al.The Lancet. HIV|April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysisTriin Umbleja, Mohammad U Zafar, Sara McCallum, et al.Travel Medicine and Infectious Disease|March 28, 2022
U.S. bound journey of migrant peoples InTransit across Dante's Inferno and Purgatory in the AmericasNelson Agudelo Higuita, Jose Antonio Suarez, Eugenia Millender, et al.Pageof 18